Randomized Assessment of TcMS for VT Storm
Ventricular Tachycardia
About this trial
This is an interventional treatment trial for Ventricular Tachycardia
Eligibility Criteria
Inclusion Criteria: ≥3 episodes of sustained VT or appropriate ICD therapies within 24 hours despite the use of at least one antiarrhythmic drug Exclusion Criteria: Plan for catheter ablation of VT in the next 24 hours Pregnancy Contraindication to TcMS (i.e. implantable ventricular assist device, metal implanted in the head or neck [except the mouth], implanted medication pumps, cochlear implant, implanted brain stimulator, ocular implant, history of malignancy in the neck)
Sites / Locations
- Hospital of the University of PennsylvaniaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Placebo Comparator
Active Comparator
Active Comparator
Sham Stimulation
Low Frequency TcMS
Theta Burst Stimulation TcMS
With the coil directed away from the patient, 600 pulses of TcMS will be delivered at minimal energy output.
With the coil directed at the stellate ganglion, 60 minutes of 1Hz stimulation will be delivered targeting the stellate ganglion.
With the coil directed at the stellate ganglion, 600 pulses of continuous theta burst stimulation will be delivered targeting the stellate ganglion.